Long-term safety and effectiveness of omalizumab in Japanese paediatric patients with severe allergic asthma: A post-marketing surveillance

被引：0
|
作者：
Nakamura, N. [1 ]
Kashitani, Y. [1 ]
Yoshisue, H. [1 ]
Nagasaki, M. [1 ]
Sasajima, T. [1 ]
机构：
[1] Novartis Pharma KK, Nishiazabu Minato Ku, Tokyo, Japan
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0153
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [1] Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, Noriko
    Kashitani, Yuka
    Yoshisue, Hajime
    Nagasaki, Makoto
    Sasajima, Takayoshi
    [J]. ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 319 - 326
  • [2] Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
    Adachi, Mitsuru
    Kozawa, Masanari
    Yoshisue, Hajime
    Milligan, Ki Lee
    Nagasaki, Makoto
    Sasajima, Takayoshi
    Miyamoto, Terumasa
    Ohta, Ken
    [J]. RESPIRATORY MEDICINE, 2018, 141 : 56 - 63
  • [3] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
    Rie Kanamori
    Shiho Yamane
    Takeshi Seto
    [J]. Advances in Therapy, 2021, 38 : 4949 - 4960
  • [4] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
    Kanamori, Rie
    Yamane, Shiho
    Seto, Takeshi
    [J]. ADVANCES IN THERAPY, 2021, 38 (09) : 4949 - 4960
  • [5] Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance
    Kuroishi, Naho
    Watananbe, Asuka
    Sakuma, Ryuta
    Ruzicka, Daniel J.
    Hara, Mitsuyoshi
    [J]. PLOS ONE, 2019, 14 (01):
  • [6] Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study
    Sakae Tanaka
    Hideki Mizutani
    Eri Tsuruya
    Ryoko Fukuda
    Kiyoka Kuge
    Naoki Okubo
    [J]. Journal of Bone and Mineral Metabolism, 2021, 39 : 463 - 473
  • [7] Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study
    Tanaka, Sakae
    Mizutani, Hideki
    Tsuruya, Eri
    Fukuda, Ryoko
    Kuge, Kiyoka
    Okubo, Naoki
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (03) : 463 - 473
  • [8] Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients
    Kenichi Namba
    Toshikatsu Kaburaki
    Hidekazu Tsuruga
    Yohei Ogawa
    Eri Iwashita
    Hiroshi Goto
    [J]. Ophthalmology and Therapy, 2022, 11 : 1147 - 1161
  • [9] Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients
    Namba, Kenichi
    Kaburaki, Toshikatsu
    Tsuruga, Hidekazu
    Ogawa, Yohei
    Iwashita, Eri
    Goto, Hiroshi
    [J]. OPHTHALMOLOGY AND THERAPY, 2022, 11 (03) : 1147 - 1161
  • [10] Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    Ilvan, Ahmet
    Nayci, Sibel Atis
    [J]. JOURNAL OF ASTHMA, 2013, 50 (06) : 687 - 694
12345